Antenatal screening with fetal echocardiography: When and how

Contemporary Ob/Gyn

Volumn 48, Issue 9, 2003, Pages 59-70

  Benoit, Richard M ^a   Copel, Joshua A ^b  

^a BROWN UNIVERSITY   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 48049093615     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hoffman JI. Congenital heart disease: incidence and inheritance. Pediatr Clin North Am. 1990;37:25-43.
2. Hoffman JI, Christiansen R. Congenital heart disease in a cohort of 19, 502 births with long-term follow-up. Am J Cardiol. 1978;42:641-647.
3. Achiron R, Glaser J, Gelernter I, et al. Extended fetal echocardiographic examination for detecting cardiac malformations in low risk pregnancies. BMJ 1992:304:671-674.
4. Ott WJ. The accuracy of antenatal fetal echocardiography screening in high- and low-risk patients. Am J Obstet Gyneool. 1995:72:1741-1749.
5. Bromley B, Estroff JA. Sanders SP, et al. Fetal echocardiography: accuracy and limitations in a population at high and low risk for heart delects. Am J Obstet Gynecol. 1992:166:1473-1431.
6. Todros T, Faggiano F, Chiappa E, et al. Accuracy of routine ultrasonography in screening heart disease prenatally. Prenat Diagn. 1997;17:901-906.
7. Shi C, Song L, Li Y, et al. Value of four-chamber view of the fetal echocardiography for the prenatal diagnosis of congenital heart disease. Zhonghua Fu Chan Ke Za Zhi. 2002:37:385-387.
8. Stumpflen I, Stumpfien A, Wimmer M, et al. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. Lancet 1996:348:854-857.
9. Michels W, Riccardi VM. Congenital heart defects. In: Emery AE, Rimoin DL. eds. Principles and Practices of Medical Genetics, 2nd ed. Edinburgh; New York Churchill Livingstone: 1990:1207-1237.
10. Nora JJ. From generational studies to a multilevel genetic-environmental Interaction. Am Coll Cardiol. 1994;23:1468-1471.
11. Burn J. Brennan P, Little J, et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 1998;351:311-316.
12. Payne RM, Johnson MC, Grant JW, et al. Toward a molecular understanding of congenital heart disease. Circulation. 1995;91:494-504.
13. Gelb BD. Genetic basis of syndromes associated with congenital heart disease. Curr Opin Cardiol. 2001:16:188-194.
14. Goldmuntz E. The epidemiology and genetics of congenital heart disease. Clin Pennatol. 2001;28:1 -10.
15. Copel JA, Cullen M, Green JJ, et al. The frequency of aneuploidy in prenatally diagnosed congenital heart disease: an indication for fetal karyotyping. Am J Obstet Gynecol. 1988;158:409-413.
16. Bull C. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British Paediatric Cardiac Association. Lancet. 1999:354:1242-1247.
17. Ryan AK, Goodship JA. Wilson DI, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet.1997;54:798-801.
18. Hernandez-Diaz S. Werler M, Walker A, et al. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med. 2000;343:1608-1614.
19. Rowland TW. Hubbell JP Jr, Nadas AS. Congenital heart disease in infants of diabetic mothers. J Pediatr. 1973, 83:815-820.
20. Miller E, Hare JW, Cloherty JP, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med. 1981;304:1331-1334.
21. Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes meliitus: a meta-analysis. OJM. 2001;94:435-444.
22. Vela-Huerta MM, Vargas-Origel A, Olvera-Lopez A Asymmetrical septal hypertrophy in newborn infants of diabetic mothers. Am J Perinatal. 2000;17:89-94.
23. Rizzo G, Arduini D, Romanini C. Cardiac function in fetuses of type 1 diabetic mothers. An J Obstet Gynecol. 1991;164:837-843.
24. Fermont L, Batisse A Piechaud JF, et al. Transitory hypertrophic cardiopathy in a newborn with a diabetic mother. Arch Fr Pediatr. 1980;37:113-115.
25. Rouse B, Azen C, Koch R, et al. Maternal Phenylketonuria Collaborative Study (MPKUS) offspring: facial anomalies, malformation, and early neurological sequelae. Am J Med Genet 1997;69:89-95.
26. Botto LD, Khoury MJ, Mulinare J, et al. Periconceptonal multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics. 1996, 98:911-917.
27. Junker R, Kotthoff S, Vielhaber H, et al. Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovas Res. 2001;51:251 -254.
28. Groves AM, Allan LD, Rosenthal E. Outcome of isolated congenital complete heart block diagnosed in utero. Heart 1996;75:190-194.
29. Glickstein JS, Buyon J. Friedman D. Pulsed Doppler echocardio-graphic assessment of the fetal PR interval. Am J Cardiol. 2000;86:236-239.
30. Barclay CS, French MA, Ross LD, et al. Successful pregnancy following steroid therapy and plasma exchange in a woman with anti-Ro (SS-A) antibodies. Case report. Br J Obstet Gynaecol. 1987;94:369-371.
31. Copel JA, Buyon JP. Kleinman CS. Successful in utero therapy of fetal heart block. Am J Obstet Gynecol. 1995, 173:1384-1390.
32. Yamada H, Kato EH, Ebina Y, et al. Fetal treatment of congenital heart block ascribed to anti-SSA antibody: case reports with observation of cardiohemodynamics and review of the literature. Am J Reprod Immunol. 1999;42:226-232.
33. Nicolaides KH, Heath V, Cicero S. Increased fetal nuchal translucency at 11 -14 weeks. Prenat Diagn. 2002:22:308-315.
34. Devine PC, Simpson LL. Nuchal translucency and its relationship to congenital heart disease. Semin Perinatol. 2000;24:343-351.
35. Michailidis GD, Economides DL. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol. 2001;17:102-105.
36. Hyett J, Perdue M. Sharland G, et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ. 1999;318:81-85.
37. Copel JA, Pilu G, Kleinman CS. Congenital heart disease and extracardiac anomalies: associations and indications for fetal echocardiography. Am J Obstet Gynecol. 1986;154:1121-1132.
38. Friedman AH, Copel JA, Kleinman CS. Fetal echocardiography and fetal cardiology: indications, diagnosis, and management .Semin Perinatol. 1993;17:76-88.
39. Copel JA Liang Rl, Demasio K, et al. The clinical significance of the irregular fetal heart rhythm. Am J Obstet Gynecol. 2000;182:813-817; discussion 817-819.
40. Schmidt KG, Ulmer HE, Silverman KH, et al. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J An Coll Canliol. 1991;17:1360-1366.